ASCVD Self-Scheduler

Basic Criteria: 

• Be 18 to 80 years old 

• Have Atherosclerotic Cardiovascular Disease (ASCVD), defined as being diagnosed with one of the following: 

• • Coronary heart disease (CHD), Cerebrovascular disease (CVD), Peripheral arterial disease (PAD) 

Answers Must Be No: 

• If female of childbearing potential, are your pregnant, breastfeeding, or planning on becoming pregnant?  

• Do you have high blood pressure that’s not controlled by medication? 

• Have you had cancer in the past 5 years? 

• Do you have class 4 heart failure (defined as symptoms of heart failure at rest and any physical activity causing further discomfort)? 

• Have you ever had a serious stroke that caused major internal bleeding? 

• Have you taken or are you currently receiving any of the following treatments? 

• • PCSK9 inhibitors for cholesterol (e.g., Evolocumab or Alirocumab) in the past 3 months 

• • Oligonucleotide or siRNA therapies (e.g., small interfering RNA) in the past 9 months (RNA-based vaccines, such as COVID-19 vaccines, are permitted) 

• • Lipoprotein Apheresis treatment to lower Lp(a) 

• Do you have Kidney Disease, Liver Disease, or other serious problems with these organs? 

• Do you have HIV, Hepatitis B, or Hepatitis C? 

Answers Must Be Yes:

• Do you have Atherosclerotic Cardiovascular Disease (ASCVD), which is defined as being diagnosed with one of the following: 

• • Coronary Heart Disease (CHD) – When the arteries that bring blood to your heart are narrowed or blocked by plaque, which can lead to a heart attack or require heart procedures like angioplasty or bypass surgery. 

• • Cerebrovascular Disease (CVD) – When blood flow to your brain is reduced or blocked, which can cause a stroke or mini-stroke (TIA). 

• • Peripheral Arterial Disease (PAD) – When the arteries in your legs or other areas outside the heart are narrowed or blocked, causing poor circulation and potentially leading to pain or serious complications. 

• If of childbearing potential and sexually active, are you willing to use a highly effect form of birth control during the study? 

• • (If using the method of oral contraception, women should be on a stable dose for 3 months before the study begins) 

• Additional criteria will apply   

PLEASE NOTE: Please confirm your eligibility before your appointment by calling 561-513-6266.

• If you do not see an available appointment, please call 561-756-8206 for availability.
• Transportation may be available.
•  Reimbursement may be available for time and travel.